Merck snags Chinese obesity drug in nearly $2 billion deal ...Middle East

Fortune - News
Merck snags Chinese obesity drug in nearly $2 billion deal
Merck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. Read More

Read More Details
Finally We wish PressBee provided you with enough information of ( Merck snags Chinese obesity drug in nearly $2 billion deal )

Also on site :